Watanabe T, Gaedicke S, Guffart E, Firat E, et al. Adding Indoximod to Hypofractionated Radiotherapy with Anti-PD-1 Checkpoint Blockade Enhances Early NK and CD8(+) T-Cell-Dependent Tumor Activity. Clin Cancer Res 2020;26:945-956.
PMID: 31694834